ONC dashboard enhanced with literature review, tool on health IT impacts

Laura Pedulli | | Health Exec | Economics

The Office of the National Coordinator for Health IT (ONC) announced new features on its Health IT Dashboard including a comprehensive literature review on the impacts of health IT on outcomes and a related interactive site.

The dashboard includes Health Information Technology: An Updated Systematic Review with a Focus on Meaningful Use Functionalities, a 145-page report prepared by RAND Corp. that updates previous systematic reviews with the new peer review literature published between 2010 and 2013. The review finds that most recent studies indicate that health IT drove significant gains in healthcare quality, but that more research is needed on efficiency and safety.

ONC also announced a complementary interactive data visualization site that allows users to browse through a sortable and interactive table of 236 new health IT studies to explore what new research evidence shows regarding the relationship between health IT and quality, safety and efficiency.

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.